Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

PRME

Prime Medicine Inc

May 26 • 04:00PM ET

2.97

0.00 0.00 %

Healthcare • Biotechnology • USA • Small • NASD

Peers: BEAM EDIT NTLA CRSP FATE

| Held by: XBI ARKG VTI IWM VXF IWN IBB VTWO SCHA VHT

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-1.25	Insider Own	47.42%	Shs Outstand	180.62M	Perf Week	5.69%
Market Cap	536.43M	Forward P/E	-	EPS next Y	-0.91	Insider Trans	0.00%	Shs Float	94.97M	Perf Month	-19.73%
Enterprise Value	515.44M	PEG	-	EPS next Q	-0.26	Inst Own	43.15%	Short Float	31.96%	Perf Quarter	-22.45%
Income	-198.37M	P/S	133.11	EPS this Y	26.13%	Inst Trans	2.75%	Short Ratio	12.01	Perf Half Y	-19.51%
Sales	4.03M	P/B	6.99	EPS next Y	8.90%	ROA	-63.69%	Short Interest	30.35M	Perf YTD	-14.41%
Book/sh	0.42	P/C	3.96	EPS next 5Y	15.49%	ROE	-216.07%	52W High	6.94 -57.20%	Perf Year	130.23%
Cash/sh	0.75	P/FCF	-	EPS past 3/5Y	2.55% -91.28%	ROIC	-108.60%	52W Low	1.18 151.69%	Perf 3Y	-78.27%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -2.32%	Gross Margin	-85.35%	Volatility	6.70% 7.22%	Perf 5Y	-
Dividend TTM	-	EV/Sales	127.90	EPS Y/Y TTM	24.20%	Oper. Margin	-5121.76%	ATR (14)	0.22	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	3.80	Sales Y/Y TTM	4.89%	Profit Margin	-4917.55%	RSI (14)	39.51	Recom	1.67
Dividend Gr. 3/5Y	- -	Current Ratio	3.80	EPS Q/Q	30.04%	SMA20	-7.00%	Beta	2.29	Target Price	7.16
Payout	-	Debt/Eq	1.49	Sales Q/Q	-41.13%	SMA50	-13.56%	Rel Volume	0.92	Prev Close	2.97
Employees	146	LT Debt/Eq	1.38	Earnings	May 07 BMO	SMA200	-25.38%	Avg Volume	2.53M	Price	2.97
IPO	Oct 20, 2022	Option/Short	Yes / Yes	EPS/Sales Surpr.	-11.60% -63.24%	Trades		Volume	2,331,000	Change	0.00%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)